Greece
- Department of Clinical Therapeutics
Durability, longevity, COVID-19, antibody, kinetics, SARS-CoV-2 variant, neutralization, anamnestic response, recall, re-exposure, Spike, Nucleocapsid, Spike-RBD, variants of concern, Alfa, Beta, Delta, Mu
SARS-CoV-2, nocebo, vaccine hesitancy, healthcare workers, tolerability, adverse event